Market Overview

Morning Market Gainers

The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen
The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved
Related ONCE
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
The Week Ahead In Biotech: Focus Shifts To Year-End Clinical Trial Results

ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) shares gained 67.30 percent to $3.53 as the company announced that data demonstrating CMX157 to be 60-fold more potent versus hepatitis B virus than Gilead's Viread.

Spark Therapeutics Inc (NASDAQ: ONCE) shares jumped 47.93 percent to $64.99 following announcement pivotal Phase 3 trial of SPK-RPE65 for genetic blinding conditions.

Yulong Eco-Materials Ltd (NASDAQ: YECO) climbed 35.74 percent to $3.00 after the company reported that it has signed a 25-year exclusive hauling & recycling agreement for Shangqiu City.

Willbros Group Inc (NYSE: WG) shares gained 30.28 percent to $1.85 after the company agreed to sell its Professional Services segment to TRC Companies, Inc. (NYSE: TRR) for $130 million in cash.

Cipher Pharmaceuticals Inc. (NASDAQ: CPHR) shares rose 17.96 percent to $4.40 after the company reported a settlement in patent litigation for Absorica.

Amicus Therapeutics, Inc. (NASDAQ: FOLD) shares climbed 14.85 percent to $7.34 after dropping 53.53 percent on Friday. Chardan Capital upgraded Amicus Therapeutics from Neutral to Buy

Keryx Biopharmaceuticals (NASDAQ: KERX) shares surged 9.66 percent to $3.51. Morgan Stanley upgraded Keryx to Equal-weight.

ANI Pharmaceuticals Inc (NASDAQ: ANIP) shares rose 8.25 percent to $47.22 after the company reported that its board has authorized a $25 million stock repurchase program.

General Electric Company (NYSE: GE) shares jumped 3.32 percent to $26.32 after Nelson Peltz's Trian Fund Management disclosed a $2.5 billion stake in GE.

Boston Scientific Corporation (NYSE: BSX) shares gained 3.01 percent to $17.43 after the company reported that it has received the FDA approval for the SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System.

Posted-In: Market GainersNews Intraday Update Markets Movers


Related Articles (BSX + ANIP)

View Comments and Join the Discussion!

Genmab Reaches $3M Milestone Payment in DuoBody Platform Collaboration with Janssen

Citi Cuts iPhone Unit Estimates Ahead Of Apple's Q4 Report